Literature DB >> 8254396

The hot spot hepatobiliary scan in focal nodular hyperplasia.

H Boulahdour1, D Cherqui, F Charlotte, A Rahmouni, D Dhumeaux, E S Zafrani, M Meignan.   

Abstract

A prospective study was performed on 14 patients with histologically proven focal nodular hyperplasia (FNH) using a hepatobiliary scan with trimethylbromoimino-diacetic acid (TBIDA) and a colloid scan with rhenium sulfur colloids. TBIDA uptake was relatively normal in the region of the tumor, but during the clearance phase 23/25 of the tumors were detected by a hot spot of radioactivity. Depending on the relative contrast achieved between the tumor and normal liver, this hot spot appeared early or later, but was always present at 60 min. In three tumors, a "doughnut" pattern was observed within the hot spot due to a central defect. Hypervascularization was observed during the perfusion phase in 76% of the tumoral sites and normal colloid uptake in only 64%. The detectability of FNH appears greater with TBIDA (92%) than with CT or MRI (84%). The high prevalence of hot spots may be due to careful technological conditions when obtaining hepatobiliary scans. Late images, overexposed films, multiple views and stimulation of gallbladder excretion increased tumor detectability. The hot spot sign may be a useful tool when combined with the results of other imaging modalities in the diagnosis of FNH. The peculiar pathology of FNH with fibrosis, hyperplastic hepatocytes and cholangiolar proliferation might explain this scintigraphic appearance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254396

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

2.  [Sequential liver scintigraphy in the differential diagnosis of focal nodular hyperplasia].

Authors:  J Bucerius
Journal:  Internist (Berl)       Date:  2005-05       Impact factor: 0.743

Review 3.  Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.

Authors:  Stefano Palmucci
Journal:  World J Hepatol       Date:  2014-07-27

4.  Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumors.

Authors:  Kazushi Numata; Manabu Morimoto; Tetsuo Isozaki; Kazuya Sugimori; Hiroyuki Oka; Kenichi Matsuo; Hiroshi Shimada; Toshio Imada; Katsuaki Tanaka
Journal:  J Med Ultrason (2001)       Date:  2007-03-15       Impact factor: 1.314

5.  Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions.

Authors:  Kenneth Coenegrachts
Journal:  World J Radiol       Date:  2009-12-31

6.  Drug induced hepatic focal nodular hyperplasia.

Authors:  A S M Bazlul Karim; Md Shafiqul Hoque; M Kamal
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 7.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.